Skin Brightening Support Helps improve skin brightness and gradually promotes a more even-looking complexion
Chicago Arthritis's overview of GLP-1, CJC-1295, AOD-9604, and related peptides lists nausea, headaches, and fluid retention as possible side effects and stresses that any peptide plan, especially a combined or "stacked" protocol, needs to be built and monitored by a knowledgeable physician (chicagoarthritis.com)
Statistical analysis A sample size of 156 participants (104 randomized to survodutide and 52 to placebo) was calculated to provide 90% overall power to demonstrate superiority of survodutide 6.0 mg over placebo for both co-primary endpoints, each at a two-sided significance level of 0.05, assuming an early treatment discontinuation rate of 15%
So, their long-term safety remains unknown
For someone on a GLP-1, this is a possible secondary upside, not a primary reason to start supplementation